Problems Continue Despite Gains In Oral Anticoagulant Use


Although significant progress has been made in recent years, a new survey from the European Society of Cardiology finds that there are still too many atrial fibrillation patients who are not taking...

FDA Panel Once Again Rejects New Indication For J&J Drug


The FDA’s Cardiovascular and Renal Drugs Advisory Committee once again turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson’s Xarelto...